Product Details for: Elahere

RETURN TO SEARCH RESULTS
PRODUCT LABEL Grayed out Product Label links indicate that there is no product label available for the product.
Product Number
Dosage Form
Route of Administration
Strength
Product Presentation
License Type
Proprietary Name
Marketing Status
001
Injection
Intravenous
100MG/20ML (5MG/ML)
Single-Dose Vial
351(a)
Elahere
Rx
Proper Name
mirvetuximab soravtansine-gynx
BLA Number
761310
Applicant
ImmunoGen, Inc.
Original Approval Date
November 14, 2022
Date of First Licensure
RETURN TO SEARCH RESULTS